共 34 条
Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII
被引:22
|作者:
Guzel, Ozlen
[1
,2
]
Maresca, Alfonso
[1
]
Scozzafava, Andrea
[1
]
Salman, Aydin
[2
]
Balaban, Alexandru T.
[3
]
Supuran, Claudiu T.
[1
]
机构:
[1] Univ Florence, Lab Chim Bioinorgan, Rm 188,Via Lastruccia 3, I-50019 Florence, Italy
[2] Istanbul Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34116 Istanbul, Turkey
[3] Texas A&M Univ, Galveston, TX 77551 USA
关键词:
Carbonic anhydrase;
Tumor-associated isoform;
CA IX;
CA XII;
Sulfonamide;
Pyridinium salt;
Antitumor agent;
IN-VIVO SELECTIVITY;
X-RAY;
ISOZYME-II;
THERAPEUTIC APPLICATIONS;
ANTITUMOR SULFONAMIDE;
MAMMALIAN ISOFORMS;
CA-IX;
DESIGN;
TARGET;
IV;
D O I:
10.1016/j.bmcl.2009.04.068
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
A series of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides possessing various 2-, 3- or 4- substituted phenyl groups with methyl-, halogeno- and methoxy-functionalities, or a perfluorophenyl moiety, has been derivatized by reaction with 2,4,6-trimethylpyrylium perchlorate. The new sulfonamides were evaluated as inhibitors of four mammalian carbonic anhydrase (CA, EC 4.2.1.1) isoforms, that is, CA I, II (cytosolic), CA IX and XII (transmembrane, tumor-associated forms). Excellent inhibitory activity was observed against hCA IX with most of these sulfonamides, and against hCA XII with some of the new compounds. These compounds were generally less effective inhibitors of hCA II. Being membrane impermeant, these positively-charged sulfonamides are interesting candidates for targeting the tumor-associated CA IX and XII, as possible diagnostic tools or therapeutic agents. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2931 / 2934
页数:4
相关论文